This real-life study compared mutation profiles and their impact on outcomes in 80 adolescent and young adults, 97 adult, and 16 pediatric chronic myeloid leukemia in chronic phase patients, alongside 81 BCR::ABL1-positive acute lymphoblastic leukemia patients.
[Leukemia]